F&P Healthcare (FPH) reported a 1H23 result at the top end of guidance with NPAT of NZ$95.9m (NZ$85-95m); Revenue of NZ$691m was ahead of guidance (NZ$670m) driven by higher hospital hardware and new apps consumables revenue slightly offset by lower traditional consumables revenue relative to our expectations
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.